We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Moderna coronavirus jab rolled out in England, adding to NHS "armoury"

Mon, 19th Apr 2021 14:42

(Alliance News) - NHS patients in England are to receive the Moderna Inc Covid-19 vaccine from Tuesday, officials have confirmed.

Stephen Powis, medical director for NHS England, said the move "marks another milestone" in the coronavirus vaccination programme.

And a member of the Joint Committee of Vaccination & Immunisation said the announcement paves the way for the next phase.

Developed in the US, the vaccine is the third to be added to the NHS "armoury", alongside those from Oxford-AstraZeneca PLC and Pfizer Inc.

The news comes as the government confirmed it has met its target of offering a Covid-19 vaccine to the highest priority groups by mid-April - those over the age of 50 and people who are clinically extremely vulnerable.

And the next phase of the vaccination programme - for healthy adults under the age of 50 - is expected to begin this week.

The Vaccines Taskforce has secured 17 million doses of the Moderna vaccine for the UK.

The jab has already been rolled out in Wales and Scotland, and the vaccine is expected to be delivered to people in Northern Ireland in the coming weeks.

The NHS in England confirmed that the Moderna jab will be delivered at more than 20 vaccination sites this week, including Reading's Madejski Stadium and the Sheffield Arena.

More sites will be able to deliver the jab as supply increases.

Powis said: "The Moderna rollout marks another milestone in the vaccination programme.

"We now have a third jab in our armoury and NHS staff will be using it at more than 20 sites from this week, with more coming online as supplies expand.

"England's vaccination programme is our hope at the end of a year like no other, so please do come forward and get your jab when you're invited.

"It is safe, quick and effective - it will protect you and your loved ones."

Commenting on the news, Adam Finn, a member of the JCVI, told BBC Breakfast: "This is enormously important; these are large numbers of doses, and it's another tool in the toolbox.

"We've got two excellent vaccines already that work really, really effectively but the more vaccines we've got, the more security over supply.

"I hope this is another step along the way and that we'll actually see more vaccines come through over the coming months and we'll have a really strong and secure supply.

"The programme hasn't been able to move forward quite as fast as it would have if there had been more vaccine supply this month.

"Having this additional supply of Moderna is clearly going to speed that up and enable us to get started on phase two and people in their 40s."

A 24-year-old carer from Wales became the first person in the UK to receive the jab last week.

Elle Taylor, from Ammanford, got the jab at the West Wales General Hospital in Carmarthen on April 7.

Almost 40 million vaccines have been delivered across the UK.

This includes more than 32 million first doses and 7.6 million second doses.

The number of first doses being delivered slowed throughout April due to supply constraints.

And the NHS has used the supply it has to offer those at highest risk their second jab.

In England around 94% of people aged 50 and over are likely to have had their first dose of Covid-19 vaccine.

And around 92% of those identified as clinically extremely vulnerable have had their first jab.

But officials have said the offer of a jab is "evergreen" and people who are yet to receive their first vaccine and are eligible to do so are still being encouraged to book into their local vaccination site.

Phase two of the programme will see the vaccine offered to younger healthy adults, most likely starting with those aged 40 to 49.

Regulators in the UK recommended that people aged 18 to 29 should be offered alternatives to the AstraZeneca vaccine, saying there is a possible link between the jab and "extremely rare" blood clots.

This means they could be offered the Pfizer or Moderna jab.

Public Health England released operational details about the Moderna jab on Monday, including information on the dose, the interval between first and second jab, the storage temperature and whether people who receive the jab will need to be observed afterwards.

The jab needs to be stored at minus 25C to minus 15C, and once it has been thawed it can be stored at 2C to 8C for up to 30 days.

The minimum interval between first and second dose of the Moderna vaccine is 28 days.

And patients who receive the Moderna jab will need to wait at the vaccination centre and be observed for a period of 15 minutes after they receive the vaccine.

By Ella Pickover, PA Health Correspondent

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
Today 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Today 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Today 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

Today 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...

26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.